A Randomized, Double-Masked, Parallel- Group, Phase 2a Dry Eye Disease Clinical Trial to Evaluate the Safety and Efficacy of Topical Ocular ADX-102, a Novel Aldehyde Sequestering Agent

被引：0
|
作者：
Clark, David [1 ]
Ousler, George W. [2 ]
Hollander, David [2 ]
Brady, Todd [1 ]
机构：
[1] Aldeyra Therapeut, Clin, Lexington, MA USA
[2] Ora Inc, Andover, MA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1967
引用
收藏
页数：2
相关论文
共 44 条
  • [41] METHODOLOGY OF A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE-RANGING, 36-WEEK, MULTICENTER TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF DAXIBOTULINUMTOXINA FOR INJECTION FOR THE TREATMENT OF UPPER LIMB SPASTICITY IN ADULTS AFTER STROKE OR TRAUMATIC BRAIN INJURY
    Munin, Michael
    Patel, Atul T.
    Brashear, Allison
    Simpson, David
    Charles, David
    Njoya, Merlin
    Rubio, Roman G.
    Snyder, Daniel
    TOXICON, 2018, 156 : S83 - S83
  • [42] Study protocol of a phase 2, randomised, placebo-controlled, double-blind, adaptive, parallel group clinical study to evaluate the efficacy and safety of recombinant alpha-1-microglobulin in subjects at high risk for acute kidney injury following open-chest cardiac surgery (AKITA trial)
    Mazer, C. David
    Siadati-Fini, Niloufar
    Boehm, Johannes
    Wirth, Felix
    Myjavec, Andrej
    Brown, Craig D.
    Koyner, Jay L.
    Boening, Andreas
    Engelman, Daniel T.
    Larsson, Tobias E.
    Renfurm, Ronny
    de Varennes, Benoit
    Noiseux, Nicolas
    Thielmann, Matthias
    Lamy, Andre
    Laflamme, Maxime
    von Groote, Thilo
    Ronco, Claudio
    Zarbock, Alexander
    BMJ OPEN, 2023, 13 (04):
  • [43] Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]
    Daniel Hänggi
    Nima Etminan
    Stephan A. Mayer
    E. Francois Aldrich
    Michael N. Diringer
    Erich Schmutzhard
    Herbert J. Faleck
    David Ng
    Benjamin R. Saville
    R. Loch Macdonald
    Neurocritical Care, 2019, 30 : 88 - 97
  • [44] Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]
    Haenggi, Daniel
    Etminan, Nima
    Mayer, Stephan A.
    Aldrich, E. Francois
    Diringer, Michael N.
    Schmutzhard, Erich
    Faleck, Herbert J.
    Ng, David
    Saville, Benjamin R.
    Macdonald, R. Loch
    NEUROCRITICAL CARE, 2019, 30 (01) : 88 - 97
12345